Skip to main
PULM
PULM logo

Pulmatrix (PULM)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Pulmatrix (PULM) Stock

About Pulmatrix (PULM)

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.
Market cap$17.82M
Today's volume5.26K
Revenue (TTM)$3K
Avg. daily volume13.14K
EBITDA (TTM)-$6.21M
Open$4.85
Price / earnings ratio-2.87x
Today's range$4.75 - $4.99
Debt / equity
52 week range$2 - $10.4
5 year debt / equity10.14x
Beta (LTM)0.66x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio19.97x
Ex-dividend date
Next earningsMar 20, 2026
Dividend payable date

Frequently Asked Questions (FAQ)

As of Nov 03, 2025, the market cap for Pulmatrix stock is $17.83M

The current P/E ratio for Pulmatrix stock is -2.87

The 52-week high for Pulmatrix stock is $10.40. The current Pulmatrix stock price $undefined is 100.00% below its 52-week high

The 52-week low for Pulmatrix stock is $2. The current Pulmatrix stock price $undefined has increased 100.00% from its 52-week low

No, the Pulmatrix stock does not pay dividends to its shareholders

How to buy Pulmatrix stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Pulmatrix stock

    Navigate to the Explore page. Then, type Pulmatrix into the search bar. When you see Pulmatrix stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Pulmatrix stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Pulmatrix Stock Earnings

The value each PULM share was expected to gain vs. the value that each PULM share actually gained.

Pulmatrix (PULM) reported Q4 2023 earnings per share (EPS) of -$0.57, beating estimates of -$1.04 by 45.19%. In the same quarter last year, Pulmatrix's earnings per share (EPS) was -$1.14. Pulmatrix is expected to release next earnings on 03/20/2026, with an earnings per share (EPS) estimate of $0.

Buy Pulmatrix (PULM) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.